Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer
Status:
RECRUITING
Trial end date:
2040-06-30
Target enrollment:
Participant gender:
Summary
Randomized phase II trial targeting early-stage breast cancer (stage II-III) applicable to preoperative chemotherapy (NAC), comparing standard treatment with multiple experimental treatments.